The Food and Drug Administration today released for comment its first plan for advancing oversight of medical software based on artificial intelligence and machine learning.

“The plan outlines a holistic approach based on total product lifecycle oversight to further the enormous potential that these technologies have to improve patient care while delivering safe and effective software functionality that improves the quality of care that patients receive,” said Bakul Patel, director of the digital health center at FDA’s Center for Devices and Radiological Health. “To stay current and address patient safety and improve access to these promising technologies, we anticipate that this action plan will continue to evolve over time.”

Related News Articles

#HealthCareInnovation Thursday Blog
Experts say that artificial intelligence (AI) is likely to have a bigger impact on health care than anything the field has experienced in our lifetime.…
Headline
The AHA today commented on the Food and Drug Administration’s draft guidance for industry and FDA staff on clinical decision support software as part of the…
Headline
The first innovation incubator likely was Thomas Edison’s lab in Menlo Park, N.J., where he and his team tinkered with emerging technology, such as the light…
Blog
The AHA Physician Alliance regularly convenes senior physician executives as part of its Physician Leadership Circle for high-level conversations on the issues…
Headline
Ever since America’s first hospital opened in 1736, hospitals and health systems have led the way in implementing medical breakthroughs that increase patient…
#HealthCareInnovation Thursday Blog
Artificial intelligence may seem like just a buzzword in health care today, but the technology is poised to significantly transform how health care is…